BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 134542)

  • 1. Membrane associated antigens of human malignant melanoma. II. Leucocyte migration studies with formalin fixed human melanoma cells.
    Suter L; Sorg C; Macher E
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):242-9. PubMed ID: 134542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
    Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
    Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
    Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
    Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formalinized tumour cells in the leucocyte migration inhibition test.
    Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
    Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of formalin-fixed melanoma cells for the detection of antibodies against surface antigens by a micro-immune adherence technique.
    Müller C; Sorg C
    Eur J Immunol; 1975 Mar; 5(3):175-8. PubMed ID: 1234054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
    Suter L
    Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
    Fukaya T; Hashimoto K; Eto H; Mehregan A
    Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
    Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
    Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
    Char DH
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
    Kristensen E
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
    Carrel S; Accolla RS; Carmagnola AL; Mach JP
    Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
    Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.